• 1. School of Pharmaceutical Sciences, Peking University, Beijing, 100191, P.R.China;
  • 2. Zhejiang Provincial Center for Occupational Hazards Prevention, Hangzhou, 310007, P.R.China;
  • 3. Department of Pharmacy, Peking University School and Hospital of Stomatology, Beijing, 100081, P.R.China;
  • 4. International Research Center for Medicinal Administration, Peking University, Beijing, 100191, P.R.China;
GUAN Xiaodong, Email: guanxiaodong@bjmu.edu.cn
Export PDF Favorites Scan Get Citation

Objectives To systematically review the implementation effects of the full coverage policy for medicines, and to provide evidence for the improvement of National Essential Medicine Policy in China.Methods We searched databases including ProQuest, PubMed, CNKI and WanFang Data databases from inception to June 30th 2018 to collect the studies on full coverage policy for medicines. Two reviewers screened literature and extracted related information independently. Then, qualitative analyses were applied to evaluate the impact of the full coverage policy for medicines.Results A total of 35 studies on the full coverage policy for medicines were included. Ten studies evaluated the effects of disease control, 12 studies evaluated the impact of the compliance of the patients, 9 studies evaluated the impact on medical expenses and drug costs, 2 studies evaluated the effects of equality, 7 studies evaluated economics, and 11 studies described the improper use and waste of medicines.Conclusions In the content of perfecting the selection mechanism and management system, the implementation of the full coverage policy for essential medicines is conducive to promoting equality and accessibility, enhancing drug compliance, improving the diagnosis and treatment of patient diseases ultimately, and making the policy more economical.

Citation: ZHAI Chenchen, ZHOU Zanrong, GUO Zhigang, ZHENG Liguang, LI Wensheng, SHI Luwen, GUAN Xiaodong. Implementation effects of the full coverage policy for medicines: a systematic review. Chinese Journal of Evidence-Based Medicine, 2019, 19(4): 481-489. doi: 10.7507/1672-2531.201808105 Copy

  • Previous Article

    The follow-up evaluation method of the implementation of WHO “Access to Essential Medicines” resolution: a systematic review
  • Next Article

    Analysis of key steps in the development of nursing clinical practice guidelines